Previous close | 17.82 |
Open | 17.75 |
Bid | 17.80 x 500 |
Ask | 17.91 x 100 |
Day's range | 17.71 - 18.22 |
52-week range | 9.50 - 18.85 |
Volume | |
Avg. volume | 1,204,393 |
Market cap | 1.613B |
Beta (5Y monthly) | 1.63 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.00 |
Earnings date | 04 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 22.90 |
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) is possibly approaching a major achievement in its business, so we would...
DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference on Monday, April 8 at 10:15 a.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90